

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51888668 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.49480057 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.46493401 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.46493401 |
| 5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45948635 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.43702536 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.43702536 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.43702536 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.43702536 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.43702536 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.43702536 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02855214 |
| 13 | detection of other organism (GO:0098543) | 3.88277897 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.87124665 |
| 15 | detection of bacterium (GO:0016045) | 3.84947571 |
| 16 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.81361578 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.70271614 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.66749211 |
| 19 | regulation of cholesterol storage (GO:0010885) | 3.64796224 |
| 20 | defense response to protozoan (GO:0042832) | 3.62429247 |
| 21 | low-density lipoprotein particle clearance (GO:0034383) | 3.57191659 |
| 22 | response to protozoan (GO:0001562) | 3.55765911 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.46584022 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.45122218 |
| 25 | mannose metabolic process (GO:0006013) | 3.43528998 |
| 26 | positive regulation of p38MAPK cascade (GO:1900745) | 3.43159779 |
| 27 | cellular response to type I interferon (GO:0071357) | 3.41833520 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.41833520 |
| 29 | cellular extravasation (GO:0045123) | 3.37328368 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.35807834 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.34231748 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.28165999 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26080764 |
| 34 | negative thymic T cell selection (GO:0045060) | 3.25585876 |
| 35 | apoptotic cell clearance (GO:0043277) | 3.21178222 |
| 36 | negative regulation of innate immune response (GO:0045824) | 3.21040180 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18466098 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16857025 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.16539411 |
| 40 | regulation of interferon-alpha production (GO:0032647) | 3.14967265 |
| 41 | negative T cell selection (GO:0043383) | 3.14820218 |
| 42 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14607807 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.10425774 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10020398 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.09356654 |
| 46 | pinocytosis (GO:0006907) | 3.08476591 |
| 47 | tolerance induction (GO:0002507) | 3.07771112 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06999847 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05467771 |
| 50 | T-helper 1 type immune response (GO:0042088) | 3.03780288 |
| 51 | leukocyte aggregation (GO:0070486) | 3.00798056 |
| 52 | B cell mediated immunity (GO:0019724) | 3.00784187 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00593322 |
| 54 | detection of biotic stimulus (GO:0009595) | 2.98925718 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98076925 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94516191 |
| 57 | neutrophil activation (GO:0042119) | 2.92575226 |
| 58 | neutrophil activation involved in immune response (GO:0002283) | 2.91032013 |
| 59 | germinal center formation (GO:0002467) | 2.90740077 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90305611 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89988959 |
| 62 | NIK/NF-kappaB signaling (GO:0038061) | 2.88392707 |
| 63 | T cell selection (GO:0045058) | 2.86752263 |
| 64 | regulation of mast cell activation (GO:0033003) | 2.86701925 |
| 65 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85956041 |
| 66 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85956041 |
| 67 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.85848206 |
| 68 | granulocyte activation (GO:0036230) | 2.85372127 |
| 69 | negative regulation of interleukin-6 production (GO:0032715) | 2.84879569 |
| 70 | positive regulation of mast cell activation (GO:0033005) | 2.84147205 |
| 71 | thymic T cell selection (GO:0045061) | 2.83342853 |
| 72 | positive T cell selection (GO:0043368) | 2.83246271 |
| 73 | interferon-gamma secretion (GO:0072643) | 2.80761309 |
| 74 | B cell homeostasis (GO:0001782) | 2.79542134 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75918447 |
| 76 | positive regulation of histone deacetylation (GO:0031065) | 2.75417398 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 2.73306025 |
| 78 | regulation of leukocyte degranulation (GO:0043300) | 2.73122114 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.72938817 |
| 80 | response to interleukin-15 (GO:0070672) | 2.72276660 |
| 81 | negative regulation of phagocytosis (GO:0050765) | 2.71479884 |
| 82 | immunoglobulin mediated immune response (GO:0016064) | 2.70421330 |
| 83 | lipoprotein transport (GO:0042953) | 2.68115945 |
| 84 | valine metabolic process (GO:0006573) | 2.67806789 |
| 85 | cellular response to interleukin-15 (GO:0071350) | 2.67325073 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65483208 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.64576009 |
| 88 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.63670475 |
| 89 | regulation of tolerance induction (GO:0002643) | 2.61995172 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60844895 |
| 91 | regulation of granulocyte differentiation (GO:0030852) | 2.60389137 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.59170499 |
| 93 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.57832823 |
| 94 | response to laminar fluid shear stress (GO:0034616) | 2.57766762 |
| 95 | T cell migration (GO:0072678) | 2.57655054 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57353452 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56544398 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 2.55796611 |
| 99 | negative regulation of granulocyte differentiation (GO:0030853) | 2.53783280 |
| 100 | regulation of p38MAPK cascade (GO:1900744) | 2.53667301 |
| 101 | response to host immune response (GO:0052572) | 2.52325637 |
| 102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52325637 |
| 103 | tricarboxylic acid metabolic process (GO:0072350) | 2.51240202 |
| 104 | phospholipid homeostasis (GO:0055091) | 2.49983052 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47879445 |
| 106 | natural killer cell mediated immunity (GO:0002228) | 2.47690332 |
| 107 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.47690332 |
| 108 | response to peptidoglycan (GO:0032494) | 2.45231225 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.41110649 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.40982244 |
| 111 | response to host (GO:0075136) | 2.40982244 |
| 112 | response to host defenses (GO:0052200) | 2.40982244 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.39316037 |
| 114 | B cell receptor signaling pathway (GO:0050853) | 2.39235893 |
| 115 | oxaloacetate metabolic process (GO:0006107) | 2.38484925 |
| 116 | regulation of sequestering of triglyceride (GO:0010889) | 2.38241826 |
| 117 | macrophage activation (GO:0042116) | 2.36775159 |
| 118 | negative regulation of lipid storage (GO:0010888) | 2.35710536 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.34743445 |
| 120 | mature B cell differentiation (GO:0002335) | 2.33913553 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33046450 |
| 122 | negative regulation of cell killing (GO:0031342) | 2.32618649 |
| 123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.32618649 |
| 124 | peptide catabolic process (GO:0043171) | 2.30863243 |
| 125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.30160286 |
| 126 | regulation of B cell differentiation (GO:0045577) | 2.29668563 |
| 127 | plasma lipoprotein particle clearance (GO:0034381) | 2.29611793 |
| 128 | regulation of phagocytosis (GO:0050764) | 2.27851753 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 2.26114391 |
| 130 | positive regulation of phagocytosis (GO:0050766) | 2.25866556 |
| 131 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.25797632 |
| 132 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.24849501 |
| 133 | positive thymic T cell selection (GO:0045059) | 2.24285836 |
| 134 | microglial cell activation (GO:0001774) | 2.24094039 |
| 135 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.22279249 |
| 136 | fatty acid transmembrane transport (GO:1902001) | 2.21908276 |
| 137 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.21423656 |
| 138 | positive regulation of lipid storage (GO:0010884) | 2.21029935 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.19834721 |
| 140 | 2-oxoglutarate metabolic process (GO:0006103) | 2.19787324 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 2.19342013 |
| 142 | mature B cell differentiation involved in immune response (GO:0002313) | 2.19316531 |
| 143 | alpha-linolenic acid metabolic process (GO:0036109) | 2.18541249 |
| 144 | respiratory burst (GO:0045730) | 2.17421398 |
| 145 | response to type I interferon (GO:0034340) | 2.17210052 |
| 146 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.16928207 |
| 147 | cell adhesion mediated by integrin (GO:0033627) | 2.16859799 |
| 148 | regulation of response to interferon-gamma (GO:0060330) | 2.16779174 |
| 149 | negative regulation of cell size (GO:0045792) | 2.16122139 |
| 150 | cellular response to zinc ion (GO:0071294) | 2.16010494 |
| 151 | stress fiber assembly (GO:0043149) | 2.15875581 |
| 152 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.15625312 |
| 153 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.15584575 |
| 154 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.15489629 |
| 155 | endothelial cell chemotaxis (GO:0035767) | 2.14842379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.58684808 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.06374091 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99755652 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84211463 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.75074952 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61130810 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52984805 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48207512 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41209044 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40810786 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40153407 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.39256547 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.38177396 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31518104 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26017449 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24477651 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24463459 |
| 18 | * MYC_22102868_ChIP-Seq_BL_Human | 2.23508638 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.23178921 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.08173669 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06928217 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01992891 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96101056 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91416957 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84669719 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84625344 |
| 27 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.84108222 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82520949 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.78325821 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76428323 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74774433 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71846085 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70087327 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69613886 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67194281 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65286228 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64602632 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64535204 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63532407 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61488856 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61451081 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61244975 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59124312 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55643082 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54033933 |
| 46 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52354990 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51562557 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51409602 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.49326508 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49286960 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49064427 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45834277 |
| 53 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44942860 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41114987 |
| 55 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39095318 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37832740 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35689498 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.34594938 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33858324 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.33040835 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31909062 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30652149 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30407177 |
| 64 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29706538 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29122753 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.29084562 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28877766 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28626772 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28619306 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28310159 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27009917 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24029876 |
| 73 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20438455 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19151493 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18165860 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17734089 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17004347 |
| 78 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16809775 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16732885 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15506287 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14424346 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14337638 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13452246 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12866958 |
| 85 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12696387 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12480693 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11778725 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11585084 |
| 89 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11528865 |
| 90 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.11356280 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11277821 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.10693392 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 1.10404303 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09781218 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09711885 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09567406 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09269245 |
| 98 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.09128297 |
| 99 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08295635 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07392473 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07027123 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06807195 |
| 103 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06727803 |
| 104 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05962726 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05491246 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04282302 |
| 107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04123939 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02669023 |
| 109 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02419156 |
| 110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02399798 |
| 111 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02336369 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02059944 |
| 113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02021255 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01829256 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01484914 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00865467 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00665570 |
| 118 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98997678 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98201316 |
| 120 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97222099 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96298387 |
| 122 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96231695 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95612694 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 0.95254926 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95192937 |
| 126 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95096278 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94925181 |
| 128 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93211599 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92795705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.30951174 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.09775290 |
| 3 | MP0009840_abnormal_foam_cell | 2.95573843 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.83090112 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.80847287 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.46473328 |
| 7 | MP0003436_decreased_susceptibility_to | 2.38506663 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.37729053 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.33341290 |
| 10 | MP0009278_abnormal_bone_marrow | 2.32955072 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.28933192 |
| 12 | MP0005360_urolithiasis | 2.05194846 |
| 13 | MP0005464_abnormal_platelet_physiology | 1.95482972 |
| 14 | MP0003724_increased_susceptibility_to | 1.88742069 |
| 15 | MP0002419_abnormal_innate_immunity | 1.85289397 |
| 16 | MP0000685_abnormal_immune_system | 1.77325931 |
| 17 | MP0006082_CNS_inflammation | 1.75830634 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.73165533 |
| 19 | MP0004947_skin_inflammation | 1.72462110 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.71622990 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 1.71622990 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.71480122 |
| 23 | MP0005387_immune_system_phenotype | 1.68877726 |
| 24 | MP0001790_abnormal_immune_system | 1.68877726 |
| 25 | MP0004510_myositis | 1.63683514 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.61987550 |
| 27 | MP0001800_abnormal_humoral_immune | 1.60276517 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.59200212 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.57130553 |
| 30 | MP0005365_abnormal_bile_salt | 1.56030125 |
| 31 | MP0005083_abnormal_biliary_tract | 1.53085712 |
| 32 | MP0005025_abnormal_response_to | 1.52793573 |
| 33 | MP0002723_abnormal_immune_serum | 1.52230279 |
| 34 | MP0005451_abnormal_body_composition | 1.51216249 |
| 35 | MP0008260_abnormal_autophagy | 1.50321454 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.50051903 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.39961822 |
| 38 | MP0001873_stomach_inflammation | 1.38244754 |
| 39 | MP0009785_altered_susceptibility_to | 1.37978549 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.36422665 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.36176935 |
| 42 | MP0001819_abnormal_immune_cell | 1.35878911 |
| 43 | MP0003252_abnormal_bile_duct | 1.35439632 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.34895483 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.34118330 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.33539342 |
| 47 | MP0000604_amyloidosis | 1.31212510 |
| 48 | MP0008469_abnormal_protein_level | 1.30205530 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.28966003 |
| 50 | MP0004381_abnormal_hair_follicle | 1.28593556 |
| 51 | MP0010307_abnormal_tumor_latency | 1.28136768 |
| 52 | MP0006054_spinal_hemorrhage | 1.27691917 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.27576188 |
| 54 | MP0009764_decreased_sensitivity_to | 1.27550467 |
| 55 | MP0000609_abnormal_liver_physiology | 1.27500902 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.27130320 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.25556696 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.25256172 |
| 59 | MP0004130_abnormal_muscle_cell | 1.24798750 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.23631845 |
| 61 | MP0005023_abnormal_wound_healing | 1.22588539 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.21817332 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.20382498 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.20283745 |
| 65 | MP0005671_abnormal_response_to | 1.19185082 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.18915435 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.17822350 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.17579488 |
| 69 | MP0000858_altered_metastatic_potential | 1.17573337 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17264284 |
| 71 | MP0002254_reproductive_system_inflammat | 1.13964884 |
| 72 | MP0003828_pulmonary_edema | 1.13307408 |
| 73 | MP0002398_abnormal_bone_marrow | 1.11819680 |
| 74 | MP0000343_altered_response_to | 1.11798152 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.08902164 |
| 76 | MP0002405_respiratory_system_inflammati | 1.08833935 |
| 77 | MP0000716_abnormal_immune_system | 1.08762955 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.08389594 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.08008048 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.07853963 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.07554216 |
| 82 | MP0002933_joint_inflammation | 1.06307065 |
| 83 | MP0003091_abnormal_cell_migration | 1.05500092 |
| 84 | MP0005670_abnormal_white_adipose | 1.04291482 |
| 85 | MP0001853_heart_inflammation | 1.03317989 |
| 86 | MP0002722_abnormal_immune_system | 1.02948608 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.02415496 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 1.01577552 |
| 89 | MP0002132_abnormal_respiratory_system | 1.01016512 |
| 90 | MP0005310_abnormal_salivary_gland | 1.00690085 |
| 91 | MP0000598_abnormal_liver_morphology | 0.99915220 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.99334137 |
| 93 | MP0003075_altered_response_to | 0.98841148 |
| 94 | MP0001958_emphysema | 0.96411656 |
| 95 | MP0002429_abnormal_blood_cell | 0.96368281 |
| 96 | MP0003866_abnormal_defecation | 0.95270878 |
| 97 | MP0004883_abnormal_blood_vessel | 0.95156483 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.94201952 |
| 99 | MP0000249_abnormal_blood_vessel | 0.93100005 |
| 100 | MP0001663_abnormal_digestive_system | 0.92918281 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.92035562 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.91694354 |
| 103 | MP0003045_fibrosis | 0.90887578 |
| 104 | MP0005164_abnormal_response_to | 0.90033117 |
| 105 | MP0005166_decreased_susceptibility_to | 0.89159387 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.88944060 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.88691594 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.87148840 |
| 109 | MP0001915_intracranial_hemorrhage | 0.86454090 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.84517729 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.84312161 |
| 112 | MP0003448_altered_tumor_morphology | 0.82493948 |
| 113 | MP0009763_increased_sensitivity_to | 0.81960742 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.81178948 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.79014156 |
| 116 | MP0002928_abnormal_bile_duct | 0.78641574 |
| 117 | MP0001851_eye_inflammation | 0.75768023 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.73778882 |
| 119 | MP0005390_skeleton_phenotype | 0.72995530 |
| 120 | MP0008004_abnormal_stomach_pH | 0.72722120 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.71598959 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.70794979 |
| 123 | MP0008874_decreased_physiological_sensi | 0.70311333 |
| 124 | MP0000371_diluted_coat_color | 0.65835918 |
| 125 | MP0003795_abnormal_bone_structure | 0.61530663 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.59837242 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.59521400 |
| 128 | MP0000490_abnormal_crypts_of | 0.57843708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mediastinal lymphadenopathy (HP:0100721) | 4.09543952 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 3.76424958 |
| 3 | Optic neuritis (HP:0100653) | 3.75654287 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.75654287 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65732867 |
| 6 | Meningitis (HP:0001287) | 3.64896747 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63701010 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63701010 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.59034541 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.57770224 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.55835230 |
| 12 | Stomatitis (HP:0010280) | 3.45196254 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 3.44817653 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.43853221 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.33420469 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.27134165 |
| 17 | Obstructive lung disease (HP:0006536) | 3.23223793 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23223793 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.20365771 |
| 20 | Encephalitis (HP:0002383) | 3.15661306 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.13559060 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12373504 |
| 23 | Mucopolysacchariduria (HP:0008155) | 3.08023728 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08023728 |
| 25 | Myocardial infarction (HP:0001658) | 3.07743409 |
| 26 | Axonal loss (HP:0003447) | 3.07182677 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.06572435 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.97045588 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94496646 |
| 30 | Pulmonary infiltrates (HP:0002113) | 2.93762733 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 2.90699821 |
| 32 | Hematochezia (HP:0002573) | 2.83717398 |
| 33 | Recurrent sinusitis (HP:0011108) | 2.82753643 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.81114876 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.81114876 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.81114876 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79805620 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79805620 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79805620 |
| 40 | Colitis (HP:0002583) | 2.79384114 |
| 41 | Urticaria (HP:0001025) | 2.78742705 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.78263719 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76069511 |
| 44 | Polycythemia (HP:0001901) | 2.74949025 |
| 45 | Hemoptysis (HP:0002105) | 2.74650278 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.74555611 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72715433 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.64334537 |
| 49 | Purpura (HP:0000979) | 2.58786162 |
| 50 | Lymphopenia (HP:0001888) | 2.58316265 |
| 51 | Glomerulonephritis (HP:0000099) | 2.55116500 |
| 52 | Myositis (HP:0100614) | 2.53942561 |
| 53 | Increased connective tissue (HP:0009025) | 2.49948214 |
| 54 | Chest pain (HP:0100749) | 2.48585486 |
| 55 | Xanthomatosis (HP:0000991) | 2.47899433 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.46972639 |
| 57 | Complement deficiency (HP:0004431) | 2.44892931 |
| 58 | Malnutrition (HP:0004395) | 2.43715833 |
| 59 | Restrictive lung disease (HP:0002091) | 2.41671739 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.40339528 |
| 61 | Abnormality of T cells (HP:0002843) | 2.39758844 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.37113902 |
| 63 | T lymphocytopenia (HP:0005403) | 2.35998783 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33439134 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.33436667 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.33174401 |
| 67 | Abnormality of T cell physiology (HP:0011840) | 2.32962664 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.31758321 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.30041742 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.29975091 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.27351949 |
| 72 | Increased CSF protein (HP:0002922) | 2.25279122 |
| 73 | Cellulitis (HP:0100658) | 2.25016438 |
| 74 | Increased serum ferritin (HP:0003281) | 2.24681028 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.24011432 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.23960354 |
| 77 | Abnormality of complement system (HP:0005339) | 2.22926298 |
| 78 | Pustule (HP:0200039) | 2.22622958 |
| 79 | Pulmonary embolism (HP:0002204) | 2.22127619 |
| 80 | Papilloma (HP:0012740) | 2.21435973 |
| 81 | Verrucae (HP:0200043) | 2.21435973 |
| 82 | Nephritis (HP:0000123) | 2.16688395 |
| 83 | Chronic diarrhea (HP:0002028) | 2.15280942 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14962336 |
| 85 | Orchitis (HP:0100796) | 2.14290691 |
| 86 | Aortic aneurysm (HP:0004942) | 2.13669026 |
| 87 | Deep venous thrombosis (HP:0002625) | 2.13444112 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.13439839 |
| 89 | Joint hemorrhage (HP:0005261) | 2.12805554 |
| 90 | IgM deficiency (HP:0002850) | 2.11147115 |
| 91 | Retinal atrophy (HP:0001105) | 2.11115282 |
| 92 | Recurrent viral infections (HP:0004429) | 2.10271089 |
| 93 | Impaired platelet aggregation (HP:0003540) | 2.09059414 |
| 94 | Abnormal platelet function (HP:0011869) | 2.09059414 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.08006798 |
| 96 | Loss of speech (HP:0002371) | 2.06304218 |
| 97 | Arthralgia (HP:0002829) | 2.05833013 |
| 98 | Esophageal varix (HP:0002040) | 2.05217094 |
| 99 | Recurrent fungal infections (HP:0002841) | 2.01480662 |
| 100 | Osteomyelitis (HP:0002754) | 1.99815293 |
| 101 | Premature loss of primary teeth (HP:0006323) | 1.99333060 |
| 102 | Increased IgM level (HP:0003496) | 1.98108550 |
| 103 | Hypochromic anemia (HP:0001931) | 1.97926929 |
| 104 | Gingivitis (HP:0000230) | 1.97607277 |
| 105 | Vasculitis (HP:0002633) | 1.97115791 |
| 106 | Anorexia (HP:0002039) | 1.96757705 |
| 107 | Periodontitis (HP:0000704) | 1.95877801 |
| 108 | Amyloidosis (HP:0011034) | 1.95706559 |
| 109 | Nasal polyposis (HP:0100582) | 1.94912109 |
| 110 | Frequent falls (HP:0002359) | 1.93720378 |
| 111 | Glomerulopathy (HP:0100820) | 1.93593205 |
| 112 | Facial diplegia (HP:0001349) | 1.93262357 |
| 113 | Conjunctival telangiectasia (HP:0000524) | 1.93104303 |
| 114 | Gangrene (HP:0100758) | 1.92983872 |
| 115 | IgG deficiency (HP:0004315) | 1.92441465 |
| 116 | Nonimmune hydrops fetalis (HP:0001790) | 1.91670950 |
| 117 | Striae distensae (HP:0001065) | 1.91473989 |
| 118 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91067226 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.91067226 |
| 120 | Pathologic fracture (HP:0002756) | 1.90945204 |
| 121 | Skin rash (HP:0000988) | 1.90831425 |
| 122 | Epidermoid cyst (HP:0200040) | 1.90305593 |
| 123 | Recurrent skin infections (HP:0001581) | 1.90196464 |
| 124 | Global brain atrophy (HP:0002283) | 1.90059930 |
| 125 | Leukocytosis (HP:0001974) | 1.89585554 |
| 126 | Hypoglycemic coma (HP:0001325) | 1.89222531 |
| 127 | Hand muscle atrophy (HP:0009130) | 1.88446168 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.87667856 |
| 129 | Fatigue (HP:0012378) | 1.86430715 |
| 130 | Emphysema (HP:0002097) | 1.85969297 |
| 131 | Tetraparesis (HP:0002273) | 1.85920029 |
| 132 | Distal upper limb amyotrophy (HP:0007149) | 1.84631696 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.84631696 |
| 134 | Peritonitis (HP:0002586) | 1.83401209 |
| 135 | Hypoalphalipoproteinemia (HP:0003233) | 1.82454631 |
| 136 | Mucosal telangiectasiae (HP:0100579) | 1.80455515 |
| 137 | Epistaxis (HP:0000421) | 1.80279197 |
| 138 | Abnormal platelet volume (HP:0011876) | 1.79474120 |
| 139 | Aneurysm (HP:0002617) | 1.79457183 |
| 140 | Nausea (HP:0002018) | 1.79303047 |
| 141 | Arterial thrombosis (HP:0004420) | 1.79099351 |
| 142 | Spondylolisthesis (HP:0003302) | 1.78423415 |
| 143 | Difficulty climbing stairs (HP:0003551) | 1.78017588 |
| 144 | Chronic otitis media (HP:0000389) | 1.75581830 |
| 145 | Thoracic kyphosis (HP:0002942) | 1.75561963 |
| 146 | Peripheral demyelination (HP:0011096) | 1.74685448 |
| 147 | Increased IgE level (HP:0003212) | 1.74642324 |
| 148 | Gingival bleeding (HP:0000225) | 1.74636060 |
| 149 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.74517019 |
| 150 | Abnormality of the thoracic spine (HP:0100711) | 1.73295729 |
| 151 | Cardiomegaly (HP:0001640) | 1.72767349 |
| 152 | Hyporeflexia of lower limbs (HP:0002600) | 1.72310668 |
| 153 | Petechiae (HP:0000967) | 1.71839568 |
| 154 | Prolonged bleeding time (HP:0003010) | 1.70608065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.13595384 |
| 2 | TRIB3 | 3.56055857 |
| 3 | PKN2 | 3.32399926 |
| 4 | TGFBR2 | 2.83636079 |
| 5 | MAP4K1 | 2.79232821 |
| 6 | MAP2K3 | 2.41957707 |
| 7 | RIPK1 | 2.21862020 |
| 8 | TTN | 2.13271447 |
| 9 | TYK2 | 2.12823743 |
| 10 | PTK6 | 2.08727819 |
| 11 | TBK1 | 2.04511552 |
| 12 | KIT | 1.90227892 |
| 13 | SIK2 | 1.85940917 |
| 14 | ZAP70 | 1.79320139 |
| 15 | KDR | 1.78510194 |
| 16 | IRAK3 | 1.75766426 |
| 17 | TAOK3 | 1.73848254 |
| 18 | TNK2 | 1.67048473 |
| 19 | PRPF4B | 1.65007321 |
| 20 | JAK3 | 1.62161819 |
| 21 | LRRK2 | 1.61217319 |
| 22 | EEF2K | 1.60958202 |
| 23 | TXK | 1.59825500 |
| 24 | JAK1 | 1.58690292 |
| 25 | TESK2 | 1.56583193 |
| 26 | RIPK4 | 1.54729253 |
| 27 | BLK | 1.54228099 |
| 28 | MAP3K3 | 1.53030248 |
| 29 | SCYL2 | 1.50264868 |
| 30 | CAMK1D | 1.47799161 |
| 31 | STK10 | 1.47433242 |
| 32 | TIE1 | 1.46066585 |
| 33 | FGR | 1.41810800 |
| 34 | TAOK1 | 1.40142652 |
| 35 | FLT3 | 1.38710199 |
| 36 | CDC42BPA | 1.37244940 |
| 37 | CSF1R | 1.36335049 |
| 38 | BCKDK | 1.29447783 |
| 39 | MAP3K10 | 1.27840434 |
| 40 | PAK4 | 1.27389489 |
| 41 | JAK2 | 1.27086997 |
| 42 | FGFR4 | 1.15851999 |
| 43 | EPHB1 | 1.13997831 |
| 44 | HCK | 1.09717809 |
| 45 | MARK2 | 1.07431863 |
| 46 | MAP3K11 | 1.07175141 |
| 47 | PRKD2 | 1.04100954 |
| 48 | BTK | 1.02111870 |
| 49 | NME2 | 1.01803382 |
| 50 | SIK1 | 1.00589081 |
| 51 | PIM1 | 1.00393241 |
| 52 | TGFBR1 | 0.99301033 |
| 53 | SYK | 0.98621662 |
| 54 | RPS6KA4 | 0.96972894 |
| 55 | CSK | 0.95355634 |
| 56 | CAMKK1 | 0.93576802 |
| 57 | IRAK1 | 0.89342184 |
| 58 | MAP3K14 | 0.88707117 |
| 59 | MAPK7 | 0.87899985 |
| 60 | MAP2K6 | 0.85035542 |
| 61 | TESK1 | 0.84855974 |
| 62 | CAMK1G | 0.84408971 |
| 63 | GRK6 | 0.83945090 |
| 64 | MAP3K1 | 0.83735671 |
| 65 | MAP3K13 | 0.82073069 |
| 66 | TLK1 | 0.80926844 |
| 67 | MAP2K2 | 0.80837691 |
| 68 | PRKCQ | 0.79672561 |
| 69 | ITK | 0.78397832 |
| 70 | PDGFRA | 0.76762617 |
| 71 | ACVR1B | 0.76641885 |
| 72 | FES | 0.76041969 |
| 73 | MAPK15 | 0.74953295 |
| 74 | BMPR2 | 0.74599458 |
| 75 | IKBKB | 0.74371185 |
| 76 | IKBKE | 0.73737772 |
| 77 | KSR2 | 0.73328854 |
| 78 | PIK3CG | 0.71659650 |
| 79 | TAOK2 | 0.70226839 |
| 80 | MAPK12 | 0.69796363 |
| 81 | SMG1 | 0.69476215 |
| 82 | RET | 0.67680421 |
| 83 | PRKCH | 0.66901651 |
| 84 | CDK6 | 0.65145314 |
| 85 | PDK1 | 0.63941470 |
| 86 | LCK | 0.63580526 |
| 87 | SIK3 | 0.63552331 |
| 88 | NEK2 | 0.62319421 |
| 89 | RPS6KA2 | 0.61973895 |
| 90 | CAMKK2 | 0.60129538 |
| 91 | IRAK4 | 0.59634912 |
| 92 | NEK9 | 0.59041488 |
| 93 | MAP3K8 | 0.57834128 |
| 94 | RPS6KC1 | 0.57785922 |
| 95 | RPS6KL1 | 0.57785922 |
| 96 | RPS6KA6 | 0.57627769 |
| 97 | EGFR | 0.56832344 |
| 98 | MAP2K1 | 0.56381448 |
| 99 | LYN | 0.56275156 |
| 100 | FGFR3 | 0.56005037 |
| 101 | TEC | 0.55813048 |
| 102 | ICK | 0.55507068 |
| 103 | MAP3K2 | 0.54005841 |
| 104 | PDPK1 | 0.54001455 |
| 105 | LMTK2 | 0.51937583 |
| 106 | MAP3K6 | 0.51493702 |
| 107 | CHUK | 0.51087625 |
| 108 | MATK | 0.50700196 |
| 109 | MTOR | 0.47630654 |
| 110 | PRKG2 | 0.46455244 |
| 111 | PIM2 | 0.46176679 |
| 112 | CDK4 | 0.45533580 |
| 113 | BMX | 0.45402354 |
| 114 | MAP3K7 | 0.45377928 |
| 115 | EPHA3 | 0.45283508 |
| 116 | IRAK2 | 0.44777755 |
| 117 | FYN | 0.44248365 |
| 118 | PDK3 | 0.44043472 |
| 119 | PDK4 | 0.44043472 |
| 120 | MAPKAPK2 | 0.42701967 |
| 121 | PDGFRB | 0.42222588 |
| 122 | ALK | 0.41849846 |
| 123 | MARK3 | 0.41436612 |
| 124 | STK11 | 0.41406793 |
| 125 | MAPK11 | 0.41395071 |
| 126 | PTK2B | 0.41323659 |
| 127 | HIPK2 | 0.40787225 |
| 128 | PAK2 | 0.40643265 |
| 129 | CDK19 | 0.39940860 |
| 130 | SGK3 | 0.39580074 |
| 131 | PRKAA2 | 0.38729473 |
| 132 | ADRBK2 | 0.38590430 |
| 133 | MAPK4 | 0.38443168 |
| 134 | STK38 | 0.38141952 |
| 135 | TRPM7 | 0.38137495 |
| 136 | DYRK1B | 0.36441084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.20703001 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.08194755 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.87300378 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.66572215 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56225677 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.55276125 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.51973997 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.39092727 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38561107 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34503948 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07556795 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05942751 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01552744 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76275104 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68062819 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62840463 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60953401 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.60608332 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59679789 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56431060 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.49193323 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45341697 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43148728 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42101719 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41993618 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40600922 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36860337 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36144456 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.36114583 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32280264 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.29782555 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29545347 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23350686 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21772518 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.20803955 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17416700 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16999494 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15559372 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14936459 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14797220 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12622113 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12399497 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08463418 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07903432 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07618747 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07120747 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.06335924 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01730012 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01683739 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01214562 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00338116 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98572169 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.98488911 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98250332 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95521900 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95299968 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.94887391 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.94406577 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92881765 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92716640 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.92662647 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92343363 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91640234 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91368862 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90930622 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87947780 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.87152368 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84634175 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84055109 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82759258 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.81189166 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.79932989 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79902768 |
| 74 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79362801 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.78098320 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.77744187 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75260070 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73632059 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72040301 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70049998 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69683748 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69226105 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.67953327 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67762994 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67753213 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67222016 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.65630120 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65000387 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.64662445 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64547035 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63679168 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62565369 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62524192 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62511678 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62010519 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61292345 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.61001104 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60179169 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59680598 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59288791 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59055360 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59009587 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58594416 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58541368 |
| 105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58431831 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57700047 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57298731 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55340170 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54969236 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54475285 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53973585 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53771148 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53519969 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.52711110 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52657533 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51635137 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50819722 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49784190 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48982296 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48446271 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47886794 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46092945 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42897915 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42780590 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42313354 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41180872 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39769847 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36568166 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36496004 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34138591 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32806834 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32087476 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31014247 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30781454 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30369264 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29538244 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29319953 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29191814 |

